Increased gap junctional intercellular communication is directly related to the anti‐tumor effect of all‐trans‐retinoic acid plus tamoxifen in a human mammary cancer cell line
- 15 April 2003
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 89 (3), 450-461
- https://doi.org/10.1002/jcb.10519
Abstract
Additive effects against tumor cells might be achieved by combining anti‐neoplastic agents directed against one or more altered mechanisms in cancer. We investigated the participation of gap junctional intercellular communication (GJIC), which is commonly dysfunctional in tumor cells as a possible mediating mechanism of the effect of all‐trans‐retinoic acid (RA) and tamoxifen (Tx) in MCF‐7 human breast cancer cell lines. The combination of RA + Tx stimulated GJIC in approximately 53 ± 3% of MCF‐7 cells as early as after 6 h of treatment remaining communicated through 144 h of culture. The GJIC enhancement occurred along with immunolocalization of Cx26 and 43 at the membrane of contacting cells and correlated with higher protein levels. Cx40 immunoreactive plaques were detected at cell‐to‐cell contacts during 48 h of RA + Tx treatment that did not involve higher protein expression, to the contrary, a downregulation occurred after 72 h of treatment. Cell proliferation inhibition upon RA + Tx exposure was observed with optimal effects at 96–120 h of culture with an accumulation of cells primarily in G2/M and G0/G1 cell cycle boundaries. An enhancement of the pre‐existing E‐cadherin levels was observed after drug exposure along with a downregulation of Bcl‐2 and C‐myc protein levels and a reduction of telomerase activity, suggesting partial tumor phenotype reversion. Blockage of the RA + Tx‐induced GJIC with 18‐β‐glycyrrhetinic acid (β‐Gly) prevented in 34% the inhibition of MCF‐7 proliferation and the E‐cadherin increment in 30% at 96 h of culture. GJIC blockage did not alter the downregulation of Bcl‐2, c‐Myc, or telomerase activity induced by RA + Tx. Our results showed the participation of GJIC as a mediator mechanism of the combined action of RA and Tx in MCF‐7 cells. The chemopreventive modulation of GJIC might represent an approachable alternative for the improvement of cancer therapy. J. Cell. Biochem. 89: 450–461, 2003.Keywords
Funding Information
- FONDECYT (1990120)
This publication has 27 references indexed in Scilit:
- Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cellsOncogene, 2002
- Retinoic Acid Inhibits Telomerase Activity and Downregulates Expression but Does Not Affect Splicing of hTERT: Correlation with Cell Growth Rate Inhibition in an in Vitro Cervical Carcinogenesis/Multidrug-Resistance ModelExperimental Cell Research, 2002
- Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cellsInternational Journal of Cancer, 2001
- Cooperation of bcl -2 and myc in the neoplastic transformation of normal rat liver epithelial cells is related to the down-regulation of gap junction-mediated intercellular communicationCarcinogenesis: Integrative Cancer Research, 2000
- Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cellsAnnals of Surgical Oncology, 1995
- Tamoxifen's role in chemoprevention of breast cancer: An updateJournal of Cellular Biochemistry, 1995
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- Endogenous and exogenous modulation of gap junctional intercellular communication: Toxicological and pharmacological implicationsLife Sciences, 1993
- Incorporation of the gene for a cell-cell channel protein into transformed cells leads to normalization of growthThe Journal of Membrane Biology, 1991
- Growth inhibition of transformed cells correlates with their junctional communication with normal cellsCell, 1986